Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05SSC
|
||||
Former ID |
DCL000513
|
||||
Drug Name |
Dalcetrapib
|
||||
Synonyms |
JTT 705; JTT-705; R-1658; RG-1658; RO-4607381; S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Dyslipidaemias; Hyperlipidaemia [ICD9: 272, 272.0-272.4; ICD10:E78] | Phase 3 | [522290] | ||
Company |
Roche
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H35NO2S
|
||||
Canonical SMILES |
CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C
|
||||
InChI |
1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26)
|
||||
InChIKey |
YZQLWPMZQVHJED-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
12015448, 14927643, 17194949, 43529910, 57371967, 79689040, 103294369, 103990387, 114788136, 124490448, 126671653, 126731316, 129871265, 134339100, 135261049, 136367976, 137157003, 142130542, 143495520, 144115880, 144221104, 152106359, 152159578, 152234923, 152258615, 160647450, 162011639, 162205179, 162221183, 163914131, 164194108, 165246672, 170498253, 174528320, 177748646, 180387047, 185972146, 198984686, 198991964, 223471416, 223664086, 226840175, 241051420, 251971148, 252160607, 252215631, 252314519
|
||||
Target and Pathway | |||||
Target(s) | Cholesteryl ester transfer protein | Target Info | Inhibitor | [551607] | |
PANTHER Pathway | CCKR signaling map ST | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.